Diwali: Karnataka govt limits bursting of crackers from 8 to 10 pm for four days

Chikkamagaluru, Jan 28: Karnataka Deputy Chief Minister and Minister for Public Works Govind Karjol on Tuesday said that he is ready to quit if the post asks him to do so to pave way for smooth expansion of the Cabinet.

Responding to a question from media persons on the issue here, he said he was ready to quit his post any time.

“If the party asks me to resign now, I will send back my official car and return by bus”, he added.

Further, he opined that there should not be efforts to seek a berth in the Cabinet based on caste.

“Putting pressure on the party based on caste is not right. The party will consider those who worked for the party and also take district-wise representation into account while filling up the vacancies”, he added.

Bengaluru, Jul 16: Life is a journey that cannot be imagined without traveling but the prevailing COVID-19 situation has made the whole world come to a standstill.

This pandemic has not only limited the modes of transportation for people all across India but also forces them to look for safer, convenient, and comfortable travel options. Private charter services are thus seen as the best alternative.
This is the reason the demand for availing charter services has risen dramatically over the last couple of months and encouraged airlines to either start or expand their charter services business further.

Many airlines have revamped their business strategies keeping charter services in mind and entered into this optimist business segment recently.

Star Air, the aviation arm of Indian business conglomerate - Sanjay Ghodawat Group, has entered into the charter services business to fulfill private air travel requirements.

The group previously has an experience of over six years of running helicopter charter service operations successfully under Ghodawat Enterprises Pvt Ltd.

The airline, Star Air, with its world-class fleet of three Embraer ERJ-145 aircraft (50-seater), two helicopters - Airbus H130 (6-seater) and Airbus H135 (5-seater), has the capacity to fly one anywhere at any point in time as per one's convenience that too with great comfort, luxury and complete privacy.

Star Air is a known name in the Indian aviation industry that is recognized for its unmatched safety, comfort, and on-time performance records.

It was praised in the past for connecting the unconnected by commencing commercial flight services to many Tier-II and Tier-III cities in India that were not graced with airline services before.

And now, after gaining the trust of over 1,00,000 customers from all across India and serving countless prominent VIP's, it has launched its charter service business.

It holds a valid license for charter service business and operates as per the protocols defined by the DGCA. The company has a team of experienced pilots, technicians, and staff that assures one gets a best-in-class charter service with complete safety and without any hassles.

"We are delighted to expand our airline operations by opening this private charter services. Like our scheduled commercial airline services, we are offering a world-class charter service keeping your comfort, safety, and overall flying experience in mind, said Sanjay Ghodawat, Chairman - Star Air.

This company had started its operations in January 2019 to connect the unconnected by providing world-class flight services at an affordable cost.

Since then it is continuing on its endeavour and gaining immense trust nationwide. It provides services to many Indian cities like Bengaluru, Belagavi, Indore, Kalaburagi, Mumbai, Ahmedabad, and Ajmer (Kishangarh).

The United States of America has bought almost the entire world's supply of remdesivir, one of just two drugs proven to treat COVID-19. 

“President Trump has struck an amazing deal to ensure Americans have access to the first authorised therapeutic for Covid-19,” said the US health and human services secretary, Alex Azar. 

“To the extent possible, we want to ensure that any American patient who needs remdesivir can get it. The Trump administration is doing everything in our power to learn more about life-saving therapeutics for Covid-19 and secure access to these options for the American people.”

The announcement implies that no other country in the world will be able to buy remdesivir for next three months at least.

The anti-viral drug patented by the US-based Gilead biotech firm is the only one approved by the European Medicines Agency (EMA) to treat patients with the novel coronavirus.

The Trump administration has already shown that it is prepared to outbid and outmanoeuvre all other countries to secure the medical supplies it needs for the US.

“They’ve got access to most of the drug supply [of remdesivir], so there’s nothing for Europe,” said Dr Andrew Hill, senior visiting research fellow at Liverpool University.

Remdesivir, the first drug approved by licensing authorities in the US to treat Covid-19, is made by Gilead and has been shown to help people recover faster from the disease. 

The first 140,000 doses, supplied to drug trials around the world, have been used up. The Trump administration has now bought more than 500,000 doses, which is all of Gilead’s production for July and 90% of August and September.